Cargando…
Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Thoracic Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600834/ https://www.ncbi.nlm.nih.gov/pubmed/30950636 http://dx.doi.org/10.1513/AnnalsATS.201810-720RL |
| _version_ | 1783431193328353280 |
|---|---|
| author | Maher, Toby M. Lancaster, Lisa H. Jouneau, Stéphane Morrison, Lake Lederer, David J. Molina-Molina, Maria Bendstrup, Elisabeth Kirchgaessler, Klaus-Uwe Gilberg, Frank Axmann, Judit Petzinger, Ute Noble, Paul W. |
| author_facet | Maher, Toby M. Lancaster, Lisa H. Jouneau, Stéphane Morrison, Lake Lederer, David J. Molina-Molina, Maria Bendstrup, Elisabeth Kirchgaessler, Klaus-Uwe Gilberg, Frank Axmann, Judit Petzinger, Ute Noble, Paul W. |
| author_sort | Maher, Toby M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6600834 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | American Thoracic Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66008342019-07-16 Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation Maher, Toby M. Lancaster, Lisa H. Jouneau, Stéphane Morrison, Lake Lederer, David J. Molina-Molina, Maria Bendstrup, Elisabeth Kirchgaessler, Klaus-Uwe Gilberg, Frank Axmann, Judit Petzinger, Ute Noble, Paul W. Ann Am Thorac Soc Letters American Thoracic Society 2019-07 /pmc/articles/PMC6600834/ /pubmed/30950636 http://dx.doi.org/10.1513/AnnalsATS.201810-720RL Text en Copyright © 2019 by the American Thoracic Society http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage and reprints please contact Diane Gern (dgern@thoracic.org). |
| spellingShingle | Letters Maher, Toby M. Lancaster, Lisa H. Jouneau, Stéphane Morrison, Lake Lederer, David J. Molina-Molina, Maria Bendstrup, Elisabeth Kirchgaessler, Klaus-Uwe Gilberg, Frank Axmann, Judit Petzinger, Ute Noble, Paul W. Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation |
| title | Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation |
| title_full | Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation |
| title_fullStr | Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation |
| title_full_unstemmed | Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation |
| title_short | Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation |
| title_sort | pirfenidone treatment in individuals with idiopathic pulmonary fibrosis: impact of timing of treatment initiation |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600834/ https://www.ncbi.nlm.nih.gov/pubmed/30950636 http://dx.doi.org/10.1513/AnnalsATS.201810-720RL |
| work_keys_str_mv | AT mahertobym pirfenidonetreatmentinindividualswithidiopathicpulmonaryfibrosisimpactoftimingoftreatmentinitiation AT lancasterlisah pirfenidonetreatmentinindividualswithidiopathicpulmonaryfibrosisimpactoftimingoftreatmentinitiation AT jouneaustephane pirfenidonetreatmentinindividualswithidiopathicpulmonaryfibrosisimpactoftimingoftreatmentinitiation AT morrisonlake pirfenidonetreatmentinindividualswithidiopathicpulmonaryfibrosisimpactoftimingoftreatmentinitiation AT ledererdavidj pirfenidonetreatmentinindividualswithidiopathicpulmonaryfibrosisimpactoftimingoftreatmentinitiation AT molinamolinamaria pirfenidonetreatmentinindividualswithidiopathicpulmonaryfibrosisimpactoftimingoftreatmentinitiation AT bendstrupelisabeth pirfenidonetreatmentinindividualswithidiopathicpulmonaryfibrosisimpactoftimingoftreatmentinitiation AT kirchgaesslerklausuwe pirfenidonetreatmentinindividualswithidiopathicpulmonaryfibrosisimpactoftimingoftreatmentinitiation AT gilbergfrank pirfenidonetreatmentinindividualswithidiopathicpulmonaryfibrosisimpactoftimingoftreatmentinitiation AT axmannjudit pirfenidonetreatmentinindividualswithidiopathicpulmonaryfibrosisimpactoftimingoftreatmentinitiation AT petzingerute pirfenidonetreatmentinindividualswithidiopathicpulmonaryfibrosisimpactoftimingoftreatmentinitiation AT noblepaulw pirfenidonetreatmentinindividualswithidiopathicpulmonaryfibrosisimpactoftimingoftreatmentinitiation |